The concept, diagnosis and treatment of IgG4-related sclerosing cholangitis

DOI
  • Ohara Hirotaka
    Department of Community-based Medical Education, Nagoya City University Graduate School of Medical Sciences
  • Nakazawa Takahiro
    Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
  • Hayashi Kazuki
    Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
  • Naitoh Itaru
    Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
  • Miyabe Katsuyuki
    Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
  • Joh Takashi
    Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences

Bibliographic Information

Other Title
  • IgG4関連硬化性胆管炎の概念・診断・治療

Search this article

Description

IgG4-related sclerosing cholangitis (IgG4-SC) is a characteristic type of sclerosing cholangitis with unknown pathogenic mechanism. IgG4-SC patients show increased level of serum IgG4 and dense infiltration of IgG4-positive plasma cells with extensive fibrosis in the bile duct wall. IgG4-SC is frequently associated with autoimmune pancreatitis, and occasionally with IgG4-related symmetrical dacryoadenitis/sialadenitis and IgG4-related retroperitoneal fibrosis. Various cholangiographic features of IgG4-SC are similar to those of primary sclerosing cholangitis, pancreatic cancer, and cholangiocarcinoma. Therefore, it is not easy to discriminate IgG4-SC from these progressive or malignant diseases on the basis of cholangiographic findings alone, and accurate diagnosis of IgG4-SC not associated with autoimmune pancreatitis is particularly difficult. The Research Committee in association with the Ministry of Health, Labor and Welfare Japan, and the Japan Biliary Association established the new clinical diagnostic criteria of IgG4-SC 2012. The criteria are believed to be practically useful for general physicians. Steroid therapy is very effective. Recently, immunosuppressive drugs have been introduced in the treatment of relapsed patients in the United States and Europe. Prognosis is generally good, however IgG4-SC cases showing liver atrophy have been reported.<br>

Journal

  • Tando

    Tando 27 (1), 92-99, 2013

    Japan Biliary Association

Keywords

Details 詳細情報について

Report a problem

Back to top